Genedrive Share Discussion Threads

[andymunchkin] 11/2/2021 09:06

oilisgold10 Feb '21 - 16:27 - 4603 of 4654
0 0 0
Your non stop rubbish is causing new Lambs to make no money, FCA you been reported to as well.
oilisgold10 Feb '21 - 16:28 - 4604 of 4654
0 0 0
There is a limit to how much rubbish and garbage you post each day saying the same
———;
IConcur pmsl

[bunz3] 11/2/2021 09:00

50,000 share buy ,

[onehanded] 11/2/2021 08:44

think AVCT is the next to blow big time. Switching from here with profits into AVCT seems a good move. Never fall in love with a stock. This has seen such a big rise.....

[iman1974] 11/2/2021 08:42

Show us your reading skills by copy and pasting the extract from an RNS that says that.

[bunz3] 11/2/2021 08:38

looking like more buyers getting back in again

[pal44] 11/2/2021 08:35

Wow swinging a lot today

[bunz3] 11/2/2021 08:10

strong start ,like this buying .

[bunz3] 11/2/2021 08:04

nice buying ,good start ,

oilisgold ,stop making things up and trying to mislead

[professor_az] 11/2/2021 07:46

Good summary Amigo! U are devious, evil and thick; they are key buzz redeeming features for you......

[stoxx67] 11/2/2021 07:42

just filter it RV2, less people comment on the garbage, sooner he goes.

[amaretto1] 11/2/2021 07:39

Totally agree with that ...ADVFN is full of themWorking for the MM ..... boiler rooms

[amaretto1] 11/2/2021 07:08

You are one sick individual !!

[aquilla] 11/2/2021 07:03

Oilisgold is desperate...and blatantly misleading. I don't know where he got that announcement.

This was the trading update last July:

"Year-end Trading Update
Revenue for the 12 month period to 30 June 2020 was GBP1.0m, in line with market expectations but below the same period in the prior year (2019: GBP2.4m) owing, as previously announced, to the significant impact of COVID-19 on the Company's pre-existing business activities. The Company ended the financial year with a much stronger balance sheet and is well-funded to execute on new opportunities in Coronavirus testing as well as the wider product development pipeline. The Company closed the year with cash balances of GBP8.2m (31 December 2019: GBP3.5m) after the successful fundraise in May 2020. Following the conversion of the US$8.0m GHIF bond on 16 June 2020 the Company has also significantly reduced the level of debt on the balance sheet."


And from November Final Results:

"Year-end cash of GBP8.2m (Dec 2019: GBP3.5m) following a successful equity fundraise in May 2020"

[oilisgold] 11/2/2021 06:41

Raise adfitional funds, its all in the RNS.

[oilisgold] 11/2/2021 06:40

Going concern

We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going concern.

[oilisgold] 11/2/2021 06:40

Jam, did you not read the RNS?

[oilisgold] 11/2/2021 06:40

Bunz Aka Sharehunter , everyone knows is a paid RAMPER

[jambam] 11/2/2021 06:40

blah blah blah no, you are the going concern you twit...you sound so desperate. Don't tell me you have got a short on here?

[oilisgold] 11/2/2021 06:39

Same as last time. Will be pumped to 300p then the dump again

[oilisgold] 11/2/2021 06:38

That was from Nov RNS, the Rampers have got rose tinted specs on

[oilisgold] 11/2/2021 06:38

Looks like placing on the way to me.

[oilisgold] 11/2/2021 06:37

Going concern

We have experienced delays commercialising the Genedrive® 96 SARS CoV-2 test and the lack of revenue has impacted our cash position. However we continue to focus on obtaining product approvals and securing sales and we are managing the cost base until revenues are assured. We are confident in our sales forecasts but securing cash generative revenue in the forthcoming months is necessary otherwise the Group will haveto reduce costs and raise additional funds. We continue to adopt a going concern basis for the preparation of the accounts, but the combination of the above factors represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going concern.

[aquilla] 10/2/2021 23:50

In case anyone needs reminding:

"genedrive plc (AIM: GDR), the near patient molecular diagnostics company, announces that it has entered into a distribution agreement with Beckman Coulter Life Sciences ("Beckman Coulter") for its Genedrive(R) 96 SARS-CoV-2 Kit. The agreement enables Beckman Coulter to sell and distribute genedrive's high-throughput COVID-19 PCR Kit in the United States and Europe for use on upper respiratory viral samples. The agreement is the result of the collaboration agreement announced in August 2020, under which the companies worked to develop and validate a fully automated PCR process for Beckman Coulter's Biomek automated workstation in conjunction with its RNAdvance Viral XP extraction kit.

The Genedrive(R) 96 SARS-CoV-2 test is ideally suited for use on the high throughput robotic Biomek i7 instrument."

[aquilla] 10/2/2021 23:40

From the LSE site:

"Good news.
Looks like the new fully automated Bio meks are already getting rolled out to help the lab technicians across the USA.
ALSO looks like demand is through the roof!!!
"We put the order in two months before we got it,” she said. “The day after we placed the order, the company told us if we hadn’t ordered it then, we would have had another several months of wait time.
"The whole country is looking for automation"
THE WHOLE COUNTRY
THE WHOLE OF THE USA"